The 2005 conference commenced with the Student Scholar Symposium, held at the Strasbourg Hilton Hotel. The main themes underlying the primary conference were well represented by the 18 student presentations. In recent years the development and implementation of ENU screening has been popularized as a tool for novel gene discovery. This year was no exception and the topic was featured in many student presentations. Yung-Hao Ching (John Schimenti's laboratory, Cornell University) described the development of a region-specific ENU screen, directed to the proximal region of Chromosome 5, and the subsequent identification of 43 mutations, including 37 embryonic lethal phenotypes in mice homozygous for the mutagenized chromosome. In addition, numerous sensitized ENU screens designed to identify specific types of mutants, including hematopoietic mutants (Nicole Anderson, University of Toronto), neural crest mutants (Ivana Matera, William Pavan, National Institutes of Health), and mutants that display late embryonic developmental phenotypes (Theresa Harboe, David Beier, Harvard Medical School), were also described. Another popular focus was presentation of the detailed mapping of several novel disease loci. Finally, a number of presentations explored the use of comparative genomics (Amy Lossie, Monica Justice, Baylor College of Medicine) to decipher important clues regarding gene function and the origins of human disease (Lawrence Kwong, William Dove, University of Wisconsin-Madison), which provided some particularly thought-provoking discussion.
Of the 18 students selected to present their work at the symposium, four were also awarded the honor of presenting their work at the primary conference. Isabelle Aubin (Jean Louis Guenet's laboratory, Institut Pasteur) was awarded for her research on the genetic mapping of the fro locus and the subsequent identification of a deletion in the sphingomyelin phosphodiesterase 3 (Smpd3) gene that gives rise to osteogenesis imperfecta in man. Valerio Conte (Aldamaria Puliti's laboratory, Gaslini Institute, University of Genova) described the genetic mapping of the Crv4 locus and the identification of an abnormal splice variant of the group I metabotropic glutamate receptor (mGluR1) gene, shown to cause a form of ataxia in mice. Jill Johnsen (David Ginsburg's laboratory, University of Michigan) reported her findings on the prevalence of a regulatory mutation in the N-acetylgalactosaminyltransferase (GALGT2) gene, which is the most common cause of prolonged aPTT (activated partial thromboplastin time) in mice and appears to have been maintained through positive selection. Finally, Marie FranceRoy (Danielle Malo's laboratory, McGill University) described the identification through linkage analysis of numerous novel loci that influence the mouse response to Salmonella. The symposium concluded with dinner held at the Hilton and provided a great opportunity to continue discussions, catch up with friends, and meet new people.
The primary conference began with the Genome Sequencing and Comparative Analysis session. One strong theme underlying this session was the importance of promoting a research environment with free exchange of comprehensive resources and information in order to facilitate novel gene discovery and achieve a greater understanding of the mouse genome and its complexities. This was reflected in the presentation of a large number of new, freely accessible online resources, including a novel comprehensive mammalian promoter map, the first whole-chromosome recombination map, optical maps based on restriction digestion, an interactive three-dimensional spatial gene expression database, and a centralized ontology resource. Common to all was the desire to promote gene discovery and provide the tools to enhance genome analysis within the mouse community.
Ewan Birney (European Bioinformatics Institute) was the plenary speaker and opened the session with a thorough update of the Ensembl resource (see www.ensembl.org). He discussed Ensembl's continuing efforts to increase accuracy in the mouse and human sequence builds and pointed out that while automated sequence annotation is providing the scientific community with progressively greater coverage with respect to gene identification, gene location, and whole-genome organization, ultimately the best way to achieve the high level of accuracy and detail desired in each of these areas is through manual sequence annotation. This point was reiterated by Deanna Church (NCBI) later in the meeting, based on her experience with the ever-evolving NCBI mouse and human genome sequence builds.
A number of new tools for gene sequence analysis and annotation now available through Ensembl were also introduced. Among these is a unique comparative genomics tool that permits the user to perform direct genome comparison across multiple species. Genomic regions from each species are stretched so that all exons appear aligned in the browser and direct interspecies comparisons can be made. Dr. Birney also described the development of bioinformatics tools for identification of promoter regions and concluded by underscoring the difficulties in understanding how the genome sequence works despite the wealth of sequence information available. He predicted a great period of discovery ahead as the mouse community strives to understand the transcriptional relevance of elements including miRNAs and antisense RNAs.
Piero Carninci (RIKEN Genome Sciences Center) described the approach his group has taken to address the transcriptional complexity of the genome by characterizing gene promoters and generating a comprehensive mammalian promoter map. He introduced the audience to the novel technology of CAGE (cap-analysis gene expression), which ''captures'' the 5¢ end of a full-length cDNA. Using this technology, over 8 million mouse 5¢ tags and approximately 5.5 million human 5¢ tags were identified and transcription start sites were identified in both the mouse (over 200,000) and the human (approximately 190,000). After mapping these sites in both genomes, a striking modality of transcription was realized, highly conserved between species. Mammalian promoters cluster in two distinct classes, a highly conserved promoter class enriched for the TATA box that initiates at a well-defined site and a less rigid class commonly containing CpG elements.
James Amos Landgraf (University of WisconsinMadison) focused on the huge gap in our ability to resolve the increasingly important repetitive elements in the genome despite an almost complete saturation of unique genomic regions. Dr. Landgraf explained his group's development of an optical map that is based on ''bar coding'' DNA fragments of approximately 500 kb by restriction digestion and then organizing these pieces into contigs that span almost 95% of the genome. This analysis platform was used to generate an optical map for the C57BL/6J genome of approximately 14,000 molecules, 240 contigs, with 95% coverage and 26· depth.
Generating genomic maps continued as the main topic with Petko Petkov (The Jackson Laboratory) describing construction of the first large-scale detailed recombination map of a mammalian chromosome (the distal region of Chr 1) using 6000 meioses from crosses of C57BL/6J · CAST/EiJ. At its most detailed, this map offers a resolution of less than 100 kb and provides insights into the features of recombination ''hot spots.'' From studying this map, it appears that hot spots vary greatly in activity along the chromosome and are not randomly distributed along the chromosome. Some large regions (>1 Mb) are completely devoid of recombination, while other genomic intervals contain multiple clusters of hot spots.
Marie Paule Lefranc (IMGT) presented data her group generated using the Immunogenetics Information System. This ontology-based system, initially developed in 1989, is specifically designed to accommodate the unique organization and diversity that exists within immunoglobulin and T-cell receptor gene families. The result is a unique and detailed classification system that Dr. Lefranc summarized in her presentation and further addressed during the Genome Sequencing and Comparative Analysis poster session. Seven separate posters (Primary authors: Geraldine Folch and Nathalie Bosc) highlighted three classes of immunoglobulin genes (Heavy, Kappa, and Lambda) and four classes of Tcell receptor genes (Alpha, Beta, Gamma, and Delta).
Laurens Wilming (Welcome Trust Sanger Institute) discussed his group's use of the completed clone-based mouse Chromosome 11 sequence to compare chromosomal rearrangements in mouse and man. In particular, he focused on two common rearrangements present on human Chromosome 17 (which is highly related to mouse Chromosome 11) that are associated with two congenital neuropathies: Charcot Marie Tooth disease (CMT), caused by a segmental duplication, and Smith-Magenis Syndrome, caused by a deletion. One of the most interesting findings presented by Dr. Wilming was the conservation of defined chromosomal breakpoints that cause CMT and SMS, respectively, between species, despite extensive chromosomal rearrangement in the CMT and SMS regions of mouse compared to human. The annotation of both the mouse 11 and human 17 chromosomes are viewable online in Vega (see www.vega.sanger. ac.uk).
Another highlight of this session was a presentation by Jeff Christianson [Medical Research Council (MRC) Human Genetics Unit] who shared an overview of EMAGE, a spatial database of in situ-based gene expression representing nearly all Theiler stages of mouse embryonic development. EMAGE serves as a computational tool for identification of coexpressed genes from in situ hybridization experiments and can be searched spatially by defining a region of interest in an embryo model or by using text terms to locate genes expressed within a region or structure. Also, this three-dimensional database circumvents the high number of variables associated with traditional text-based searches, including unreported expression patterns and differences in term usage in the literature (see genex.hgu.mrc.ac.uk/Emage/database/emageIntro.html for details).
Judith Blake (The Jackson Laboratory) presented the development of centralized information systems aimed at enhancing discovery. Her topic of discussion was the Gene Ontology (GO) system, a structured vocabulary system developed at The Jackson Laboratory that provides ontologies for the functional annotation of all organisms. In addition to the GO system, Dr. Blake discussed multiple bio-ontology resources, including the Mammalian Phenotyping Ontology and the Anatomical Dictionary for Mouse. Her group is integrating information from these various resources to create a common bioontology system. Such a resource will be extremely useful for genomic studies, particularly the study of human diseases modeled in the mouse.
With the first session complete, the amiable Jean Louis Guenet of the Pasteur Institute in Paris introduced Yoshihide Hayashizaki, Director of the RIKEN Genomic Sciences Center, who gave the Verne Chapman Memorial Lecture. Dr. Guenet is one of the founding fathers of mouse genetics and organized the first and the tenth IMGS meetings in Paris in 1986 and 1996. He was an early champion of the use of wild strains of mice for genetic mapping (Avner et al. 1988 ). Dr. Guenet is a reliable source of humor, collegiality, and scientific vision at these meetings and everyone looks forward to his continued participation.
The Verne Chapman Memorial lecture was instituted in 1995 to honor Dr. Chapman's many contributions to mouse genetics and to the International Mammalian Genome Society. He was instrumental in stimulating groups of mouse geneticists to work together in generating genetic maps for every mouse chromosome and he championed the idea that IMGS would be a true international entity, inclusive of mouse geneticists all over the world. His own research on regulation of X chromosome gene expression and use of interspecific hybrids for mapping and chimera analysis was ground breaking. Dr. Hayashizaki is also a recognized leader in the IMGS. He hosted the 2000 meeting in Narita, Japan, and will again welcome geneticists from all over the world to the IMGS meeting in Kyoto, Japan, in 2007.
Drs. Hayashizaki and Chapman were close friends and collaborators and visited each other frequently. Dr. Hayashizaki gave a touching and personal tribute to Dr. Chapman and reviewed the advances in mouse genetics that arose from their collaboration and from subsequent research by Dr. Hayashizaki and colleagues. One of the techniques that Drs. Chapman and Hayashizaki worked on together is known as Restriction Landmark Genome Sequence (RLGS) (Hayashizaki, et al. 1993 ). This method was used to map the underlying genetic cause of cardiomyopathy in the hamster, which quickly led to the identification of the mutated sarcoglycan gene. The RLGS method was also used to clone the ataxic mouse mutant ''reeler'' and to identify imprinted genes.
As Project Director of the Genome Sciences Laboratory in Japan in 1995, Dr. Hayashizaki proposed development of the whole mouse genome encyclopedia project shortly before Dr. Chapman's untimely death during a visit to Japan. The outcome of this work constitutes a huge contribution to the scientific community, including mouse geneticists and biologists studying the fundamentals of gene regulation. While the sequence of the genome provides one window into our genetic makeup, the transcripts produced add a level of complexity that will provide crucial clues for linking genotype to phenotype. Dr. Hayashizaki and colleagues developed wet lab techniques, process engineering, and bioinformatics necessary to give us a window into the nature of what is transcribed from the genome. The huge numbers of noncoding RNA and antisense transcripts discovered in this international effort have revealed a novel view of the genome and the nature of ''genes.' ' The second day of the conference began with the Models of Human Disease session. Arguably this continues to be one of the most popular and exciting sessions of the IMGS meetings because it highlights the biological insights gained from mouse models of human disease. Pierre Chambon (Institut Clinique de la Souris) delivered the plenary presentation, which focused on the genetic dissection of retinoid signaling through cell-specific temporally controlled targeted mutagenesis. Dr. Chambon is a leader in the field of developing technologies for inducible gene expression (see Mark et al. 2005 for recent review).
The session continued with two talks focused on Down Syndrome. Elizabeth Fisher (Institute of Neurology, University College London) presented a phenotypic analysis of an aneuploid mouse strain with the first germline transmission of an entire human Chromosome 21. Down Syndrome is likely the result of an abnormal dosage of numerous genes; current models may not accurately represent the human phenotype since they are single-gene models or are only partially trisomic. Using a technology initially developed by Oshimura and colleagues, the Fisher laboratory produced two embryonic stem (ES) cell lines (of 2500) that contained a freely segregating human Chromosome 21 with approximately 92% of all Chromosome 21 genes. Mice segregating this human chromosome were generated and their phenotype included many features of the human syndrome such as defects in synaptic plasticity and hippocampus-based learning, cerebellar neuronal degeneration, heart defects, and craniofacial abnormalities (see O
Both in vitro and in vivo studies revealed a reduced response to Shh signal in trisomic gcp and populations of gcp cells were restored in newborn trisomic mice treated with a Shh agonist. Amelioration of the neural deficit in trisomic mice identifies a potential target for clinical interventions of cognitive disability in human trisomy 21.
The remaining presentations of the session were diverse in disease topic, but many addressed outcomes of ongoing ENU mutagenesis screens. Previous meetings have featured plans and progress of such screens but this meeting clearly highlighted how the identification of important biological pathways and genes underlying human disease has been facilitated by high-throughput mutagenesis projects.
Karen Svenson (The Jackson Laboratory) outlined progress made over the last five years in The Jackson Laboratory's Heart, Lung, Blood and Sleep Mutagenesis Program. The premise for this project, initiated in 2000, was to perform large-scale ENU mutagenesis with high throughput and robust phenotyping screens designed specifically for mice. Through these efforts over 60 heritable mutants have been identified and the phenotyping protocol has been validated as an effective, unbiased tool for identification of potential disease-causing genes in humans. In concluding, Dr. Svenson advertised the fact that as a result of this project, The Jackson Laboratory is now in possession of a large number of mouse mutants, characterized only by their phenotype. All of these mutant strains are available by request for further detailed study.
Yoichi Gondo (RIKEN Genomic Sciences Center) described the RIKEN Mouse Mutagenesis Project, an initiative aimed at identifying mouse models for common human diseases by taking a reverse genetics approach. To immortalize potentially interesting mouse strains, a bank of mutants was generated by cryopreserving ENU-mutagenized G 1 sperm. The 8000 G 1 sperm samples are being screened for ENU-induced mutations in 195 genes of interest. Thus far, 200 mutant lines have been identified and 30 live mouse strains generated. This resource, like many others described during the conference, is freely accessible to the mouse community through an online catalogue (see www.gsc. riken.go.jp/Mouse/).
Eleni Douni (Biomedical Science Research Center, Alexander Fleming) described a sensitized ENU screen her group used to identify modifiers of the TNF DARE arthritis and Crohn's-like Inflammatory Bowel Disease (IBD) disease models. Using phenotypic screens for clinical manifestations of arthritis coupled with histologic analysis, mice were selected that demonstrated a delay in the onset of disease. Of 4303 G 3 families screened, 3 displayed delayed arthritic onset and 2 demonstrated a drastic reduction in the severity of IBD. Dr. Douni concluded by explaining that her group is now focused on identifying potential disease susceptibility loci in these mice through an F 2 intercross genetic mapping approach combined with genome-wide microsatellite mapping.
Tom Van Agtmael (University of Edinburgh) discussed characterization of the type IV collagen gene, Col4a, using an ENU-induced allelic series. The three dominant mutations identified revealed basement membrane defects in mouse eye, kidney, and other tissues. Interestingly, mutations affecting the collagen domain caused dominant negative effects on the expression and function of the major collagen IV isoforms and the extent of pathologic effects were allele specific.
Thomas Meehan (Monica Justice's laboratory, Baylor College of Medicine) also presented data from an allelic series identified in an ENU screen. The melanocortin-4 receptor gene (Mc4R) is a gene shown to have a role in obesity in both mice and humans. Critically, in humans it appears that the severity of obesity increases as the levels of functional receptor decrease. The Mc4R allelic series in mice mimics the human phenotype, demonstrating the power of this allelic series and its application for studying variation in obesity found in humans with MC4R mutations.
Another interesting ENU-themed database was highlighted in the last talk of this session, presented by Chen-Pei Tu (Academia Sinica). Dr. Tu's group developed specialized phenotyping strategies to identify potential mouse models of neurologic, cardiovascular, renal, hematologic, and metabolic diseases. Dr. Tu reported some unique models identified using the group's phenotyping screen, including mouse models of human maple syrup urine disease, fatty acid oxidation defects, and lymphopenia. Current work is now focused on continuing to characterize these mutants with respect to heritability and the genetic mapping of potential disease loci. Overall, this work represents another useful resource for the study of human disease.
At the conclusion of the session, Deanna Church (NCBI) lead an open forum to discuss progress on assembly and annotation of the C57BL/6J mouse genome sequence. A number of important issues were raised during the discussion relating to the accuracy of sequence annotation and assembly. The overwhelming opinion was that the current genome sequence available for the mouse is not yet optimal. During the discussion, Dr. Birney (European Bioinformatics Institute) suggested that manual annotation, although very time consuming, may be required to achieve the desired level of accuracy. There was a suggestion that by working together as a community, this time may be greatly reduced thus benefiting everyone. Dr. Church also announced that the final NCBI mouse build (for the time being) would be released early 2006 (see www.ncbi.nlm. nih.gov/).
Attendees were then invited to a concert at The Church of Saint Pierre le Jeunne, built in the 12th century and one of the most beautiful churches in Strasbourg. The concert featured the Ensemble vocal La Frattola. The audience was treated to a wonderful program that included the music of Bach, Mendelssohn, and Pachelbel. Dinner followed at one of the oldest restaurants in Strasbourg, La Maison Kammerzell, built in 1427. While a little daunting at first, the entré e of three-fish sauerkraut was a great experience, bringing to a close a great day in Alsace.
The third day of the conference began with a session on Stem Cells, a new inclusion in the conference in 2005. Shin-Ichi Nishikawa (Kyoto University) delivered the plenary lecture, discussing the application of DNA microarray technology to stem cell research. Dr. Nishikawa described his group's efforts to establish a DNA microarray database that compares two subpopulations of stem cells in the body, resting cells and ''self-renewing cells'' (embryonic stem cells). Critical to the experimental design was the ability to correctly sort different populations of stem cells; this was achieved via fluorescence-activated cell (FAC) sorting. A software platform that allows simultaneous multiple-data-point comparisons was developed to analyze gene expression patterns in the stem cell populations. Dr. Nishikawa concluded by discussing the application of this database to identify specific markers that differentiate stem cell subpopulations. Once again, this is a freely available resource for the mouse community (see www.cdb.riken.go.jp/scb/).
In a fascinating presentation, Neal Copeland (National Cancer Institute) remained true to the theme of the session, introducing the idea of a ''cancer stem cell.'' By developing high-throughput methods for cloning and sequencing retroviral integration sites in mouse tumors and using the recently released draft sequence of the mouse genome, Dr. Copeland's laboratory has accelerated the identification of new cancer genes via insertional mutagenesis. More than 250 candidate cancer gene loci have been identified, including several that encode genes validated in human cancer. Many other loci represent potentially novel human cancer genes. For more details see ccr.cancer.gov/staff/staff.asp?profileid=5565.
The remaining presentations in this session continued to emphasize the power of ENU screens, including results of a sensitized mouse mutagenesis screen for novel loci regulating mammalian neural crest development presented by William Pavan (National Institutes of Health).
The Development session commenced next with Denis Duboule (University of Geneva) delivering the plenary presentation on the role of homeobox (Hox) genes in limb development. Many of the presentations in this session shared an underlying theme of sonic hedgehog (Shh) signaling pathway regulation.
Of special interest was a presentation by Pamela Tran (Brigham and Women's Hospital, Boston), recipient of this year's prestigious Verne Chapman Young Scientist Award for her identification of a novel regulator of mouse Shh signaling. Her work, conducted in the laboratory of Dr. David Beier (Harvard Medical School), reported the characterization of the alien (aln) allele, which results in a phenotype characteristic of inappropriate Shh signaling. Consequences of this mutation include preaxial polydactyly, craniofacial abnormalities, and misexpression of Shh target genes in the neural tube and limb bud. Using positional cloning, Dr. Tran identified a missense mutation in the evolutionarily conserved N-terminal amino acid of Thm1 [tetratricopeptide repeat (TPR)-containing hedgehog modulator 1]. Her work suggests a critical role for Thm1 in the regulation of the glioblastoma3 (Gli3) gene, a vital component of the Shh signaling pathway required to activate downstream target genes.
The Epigenetics, Chromosomes and Chromatin session was kicked off by Wendy Bickmore (MRC Human Genetics Unit) who provided a great introduction to the remarkable role of chromatin in ensuring the stability of DNA, regulating gene expression, and affecting chromosome replication. Dr. Bickmore then focused on the role of chromatin structure in regulating the expression of gene clusters. This work is summarized nicely in a recent review by Sproul et al. (2005) .
Other speakers in this session included Christine Disteche (University of Washington) who discussed X chromosome expression in spermatids and secondary oocytes, and Hiroki Nagase (Roswell Park Cancer Institute) who presented the first draft of a C57BL/6J genome DNA methylation map.
The final day of the conference began with the Immunity and Infection session. Jules Hoffman (Insitut de Biologie Moleculaire et Cellulaire) delivered the plenary talk, which focused on studying control of gene expression in the Drosophila immune response. Most interestingly, Dr. Hoffman discussed an unexpected finding that a pathway shown to be responsible for directing dorsoventral patterning in the early embryo also serves for immune gene expression.
Igor Kramnik (Harvard School of Public Health) shifted focus to the mouse and discussed the mapping of a major genetic locus, sst1 (susceptibility to tuberculosis 1), and the subsequent identification of a candidate gene for tuberculosis resistance, intracellular pathogen resistance 1 (Ipr1). Joseph Nganga (Jomo Kenyatta University of Agriculture) concluded the session by presenting his research on mouse strain-specific responses to trypanosomiasis.
The final session of IMGC 2005 focused on Complex Traits, with a broad emphasis on the significance of epistasis in modulating phenotypes regulated by quantitative trait loci (QTL). Overall, research presented during the session demonstrated that the power of this approach for elucidating the complexities of human disease could be improved in two ways. First, the genetic diversity of mouse populations used for mapping QTL could be increased and, second, maternal effects on adult phenotypes need to be better understood.
The Complex Traits session began with Gary Churchill (The Jackson Laboratory) addressing difficulties the mouse community has experienced in finely mapping susceptibility alleles that influence complex diseases and traits. Dr. Churchill explained that the lack of success is a result of inheritance of complex phenotypes being fundamentally different from typical Mendelian traits. He encouraged the mouse community to envision complex traits as products of interactions among multiple loci selected to be inherited together. He went on to suggest that the genomes of common inbred laboratory strains of mice contain large genetic networks in linkage disequilibrium due to intense selection during inbreeding. Uncovering the relationships between these coadapted alleles and complex diseases will not be accomplished using single-gene approaches, such as ENU mutagenesis, that focus on maladaptive mutations. Instead, characterization of recombinant inbred sets generated from many diverse inbred strains will allow the community to investigate how interactions between naturally occurring gene variants and the environment influence complex phenotypes.
David Sinasac (Joe Nadeau's laboratory, Case Western Reserve University) discussed how the B6-Chr A chromosomal substitution strains (CSS) can be used as a tool to dissect the genetics of obesityassociated risk factors for cardiovascular disease, diabetes, and stroke in a diet-induced model of metabolic syndrome (MetS). Most strains fed a highfat, high-sucrose diet showed a high correlation among obesity-related physiologic traits (insulin resistance, dyslipidemia, fatty liver, etc.). However, several CSS strains exhibited unpredicted relationships between physiologic measurements and body mass index, suggesting that the study will be able to address whether MetS is primarily a product of susceptibility for obesity or if physiologic relationships between MetS traits are modulated independently by genetic background.
Joseph Jarvis (Washington University) described reciprocal crosses between B6 and LGXSM RI strains to investigate whether maternal effects (pre-and postnatal) on offspring phenotypes have a genetic basis in the maternal generation (intergenerational epistasis). Physiologic trait values measured in adult offspring were significantly different when siblings were compared to genetically identical adults from a reciprocal cross, indicating that maternal environment influences an offspring's characteristics into adulthood. Interactions were detected between maternal care and offspring response to dietary fat intake, but data did not support the well-described ''thrifty phenotype'' hypothesis in which poor prenatal nutrition leads to adult type 2 diabetes and heart disease.
Continuing the maternal effects theme, JeanJacques Panthier (Institut Pasteur) discussed physiologic and genetic characterization of intestinal length in PRM/Alf inbred mice, which exhibit intestines 60% longer than other mouse strains. The lengthening was found to occur postnatally and cross-fostering experiments showed that a synergistic interaction between the PRM offspring genome and maternal environment contributes to the long intestine phenotype.
Karlyne Reilly (National Cancer Institute) described modifiers of peripheral nerve sheath tumors (PNST) in the NPcis (heterozygous for NF-1 and p53 null alleles in cis) mouse model of neurofibromatosis type 1. Offspring from crosses between NPcis fathers and wild-type mothers showed consistently higher tumor incidence than offspring from the reciprocal cross, suggesting that a maternally expressed imprinted locus linked to p53 and NF-1 reduces tumor number in this model. Interestingly, interactions between the imprinted allele and additional nonlinked modifiers were also detected. These modifiers are probably relevant to human NF-1 since human PNST show translocations involving the conserved syntenic regions.
A special session was held to review the purpose, goals, and accomplishments of the Complex Trait Consortium (CTC). Richard Mott (Wellcome Trust) described the Wellcome CTC Mouse Strain SNP Genotype set, a database of 13,370 SNPs genotyped in 480 inbred and recombinant inbred (RI) strains that is publicly available at www.well.ox.ac.uk/ mouse/INBREDS. Gary Churchill discussed the Collaborative Cross (CC), a new 1000-line RI set being generated from eight diverse parental strains. He explained why the mixing of diverse genomes is required to generate more animal models truly representative of complex human diseases. Elissa Chessler (Oak Ridge National Laboratory) concluded the session by demonstrating the power of a reference population (such as the CC) for integrating classical phenotypes with data from new highthroughput methods such as gene expression quantification.
After almost five days packed full of stimulating science, IMGC 2005 drew to a close with a conference banquet held at the Auberge du Kochersberg, the oldest Auberge or Inn in the Alsace region. Numerous awards were presented for outstanding oral presentations and excellent posters (see Table 1 for a summary), and a special honor was given to Jean Louis Guenet, who has just retired. Talking with attendees, the overall feeling was that this meeting had been fabulous-from the quality of the science presented, in particular the coupling of cutting-edge resources and their application to the study of models of human disease, to the venue, which was a true highlight, to the organization and to the people involved! Another endearing quality of the meeting was its intimacy, which promoted both strong scientific and social interaction.
So after a big year in France we are looking forward to the 2006 conference, which marks the 20th anniversary of the IMGC! This promises to be a great meeting and will be held in Charleston, South Carolina. For more information see www.imgs.org.
